Enliven Therapeutics Inc (ELVN)
Financing Cash Flow
$473.73M
TTM · Period ending: · USD
ELVN Financing Cash Flow
Latest reported$473.73Mperiod ending
Latest reported$473.73Mperiod ending
ELVN TTM Cash from Financing ($43.58M → $473.73M)
TTM financing cash flow
High-resolution chart · PNG
ELVN financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 473,726,000 | |
| 228,686,000 | |
| 218,867,000 | |
| 258,216,000 | |
| 259,701,000 | |
| 43,129,000 | |
| 133,165,000 | |
| 93,283,000 | |
| 91,741,000 | |
| 87,115,000 | |
| 234,286,000 | |
| 231,819,000 | |
| 232,408,000 | |
| 235,233,000 | |
| -1,799,000 | |
| 568,000 | |
| 47,395,000 | |
| 49,050,000 | |
| 49,101,000 | |
| 49,708,000 | |
| 2,852,000 | |
| 10,785,000 | |
| 96,881,000 | |
| 94,288,000 | |
| 94,153,000 | |
| 86,208,000 | |
| 43,579,000 |